Gustavo Oderich, M.D., FACS
Professor and Chief, Division of Vascular Surgery and Endovascular Therapy
(713) 798-5700Positions
- Professor and Chief, Division of Vascular Surgery and Endovascular Therapy
-
糖心视频 of Medicine
- Michael E. DeBakey Distinguished Endowed Chair in Surgery
-
糖心视频 of Medicine
- Director, Center for Aortic Surgery
-
糖心视频 of Medicine
Addresses
- Baylor Medicine at McNair Campus (Clinic)
-
7200 Cambridge Street
Houston, TX, 77030
United States
Phone: (713) 798-5700
Education
- Fellowship at Cleveland Clinic Foundation
- Cleveland, OH
- Advanced Endovascular
- Clinical Fellowship at Mayo Clinic College of Medicine and Science
- Rochester, MN
- Vascular Surgery
- Residency at Mayo Clinic College of Medicine and Science
- Rochester, MN
- General Surgery (Categorical)
- Research Fellowship at University of Utah
- Salt Lake City, UT
- Vascular Surgery
- Residency at Universidade Federal do Rio Grande do Sul
- Porto Alegre, Brazil
- General Surgery
- MD from Universidade Federal do Rio Grande do Sul
- Porto Alegre, Brazil
Certifications
- General Surgery
- American Board of Surgery
- Vascular Surgery
- American Board of Surgery
Honors & Awards
- Who鈥檚 Who in America
- Marquis (2012-2025)
- Distinguished Fellow
- Society for Vascular Surgery
- Distinguished Lecturer
- Roy Greenberg Society for Vascular Surgery
- Global Career Advancement Award
- VIVA
Professional Interests
- Aortic arch aneurysms and dissections
- Aortoiliac aneurysms
- Thoracoabdominal aortic aneurysms and dissections
- Endovascular and thoracic endovascular aortic repair (EVAR/TEVAR)
- Fenestrated and branched endovascular aortic repair
- Complex open surgical aortic repair
- Renal and mesenteric artery disease
- Onco-vascular procedures
Professional Statement
Dr. Gustavo Oderich focuses on the clinical evaluation, open surgical and endovascular treatment of aneurysms, dissections, trauma, and aortic pathology involving any segment of the aorta, including the aortoiliac, juxtarenal, pararenal, complex abdominal, thoracoabdominal and aortic arch. Dr. Oderich has a broad and extensive experience in a wide spectrum of arterial and venous diseases affecting all vascular beds, including carotid, supra-aortic trunk, upper and lower extremity, abdominal and pelvic vessels.
Dr. Oderich is a world-renowned authority on innovative minimally invasive endovascular techniques to treat complex aortic aneurysms using fenestrated and branched stent grafts. He pioneered several techniques of physician-modified endovascular grafts (PMEGs) that are currently utilized in many centers and was instrumental in the development, technical improvements and dissemination of fenestrated and branched stent-grafts using multiple designs. Dr. Oderich serves as the Global Principal Investigator for the ongoing Cook Zenith Plus Pivotal Study and the upcoming Thoraco Plus Pivotal Study and is a principal investigator and member of the steering committee in numerous trials. He served as Chair for the Society for Vascular Surgery Reporting Standards on endovascular repair of complex aneurysms and is a member of the writing committee of clinical practice guidelines for the management of aortic diseases from the American Heart Association, American Society for Vascular Surgery and the European Society for Vascular and Endovascular Surgery. Dr. Oderich has several firsts, including the 鈥渇irst-in-man鈥 implant of the antegrade WL Gore TAMBE stent-graft (Thoraco-Abdominal Multi-Branch Endoprosthesis), the first-in-man implant of the Cook ZFEN Plus stent-graft and the first-in-man total trans-femoral three vessel arch device using antegrade branches. Dr. Oderich extensive clinical experience includes thousands of patients treated by open surgical and endovascular procedures. He has performed over 2,000 standard endovascular and thoracic aortic repairs (EVARs/TEVARs) and nearly 900 fenestrated-branched, fenestrated and branched endovascular repairs (FB-EVAR, FEVAR, BEVAR).
Dr. Oderich clinical experience as a leader in vascular surgery spans over two decades. He served as immediate past chair of the Vascular and Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota (2006-2020) and at The University of Texas Health Science Center in Houston (2020-2024). Dr. Oderich was mentored by pioneering surgeon Roy Greenberg at the Cleveland Clinic and continues to perfect techniques of complex endovascular repair. His clinical practice at the Mayo Clinic was extensive rapidly accumulating one of the world鈥檚 largest experiences in aortic disease, where he led and build an advanced endovascular aortic program over the last two decades. He is one of ten surgeons in the United States, and the only surgeon in Houston to have physician-sponsored, Food Drug Administration (FDA) approved access to the entire pipeline of company-manufactured fenestrated and branched stent-grafts to treat aortic arch, thoracoabdominal and complex abdominal aortic aneurysms. Dr. Oderich has also a versatile open surgical and endovascular practice in other areas, including the management of carotid, supra-aortic trunk, renal, and mesenteric artery diseases. He is also involved in the multidisciplinary care of patients with connective tissue or heritable disorders including Marfan鈥檚, Loeys-Dietz Syndrome and Vascular Ehlers Danlos Syndrome. Dr. Oderich is also devoted to surgical education and the dissemination of these techniques, having mentored to over 100 residents, fellows and post-graduate students. He is considered one of the most influential aortic surgeons worldwide.
Dr. Oderich is a world-renowned authority on innovative minimally invasive endovascular techniques to treat complex aortic aneurysms using fenestrated and branched stent grafts. He pioneered several techniques of physician-modified endovascular grafts (PMEGs) that are currently utilized in many centers and was instrumental in the development, technical improvements and dissemination of fenestrated and branched stent-grafts using multiple designs. Dr. Oderich serves as the Global Principal Investigator for the ongoing Cook Zenith Plus Pivotal Study and the upcoming Thoraco Plus Pivotal Study and is a principal investigator and member of the steering committee in numerous trials. He served as Chair for the Society for Vascular Surgery Reporting Standards on endovascular repair of complex aneurysms and is a member of the writing committee of clinical practice guidelines for the management of aortic diseases from the American Heart Association, American Society for Vascular Surgery and the European Society for Vascular and Endovascular Surgery. Dr. Oderich has several firsts, including the 鈥渇irst-in-man鈥 implant of the antegrade WL Gore TAMBE stent-graft (Thoraco-Abdominal Multi-Branch Endoprosthesis), the first-in-man implant of the Cook ZFEN Plus stent-graft and the first-in-man total trans-femoral three vessel arch device using antegrade branches. Dr. Oderich extensive clinical experience includes thousands of patients treated by open surgical and endovascular procedures. He has performed over 2,000 standard endovascular and thoracic aortic repairs (EVARs/TEVARs) and nearly 900 fenestrated-branched, fenestrated and branched endovascular repairs (FB-EVAR, FEVAR, BEVAR).
Dr. Oderich clinical experience as a leader in vascular surgery spans over two decades. He served as immediate past chair of the Vascular and Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota (2006-2020) and at The University of Texas Health Science Center in Houston (2020-2024). Dr. Oderich was mentored by pioneering surgeon Roy Greenberg at the Cleveland Clinic and continues to perfect techniques of complex endovascular repair. His clinical practice at the Mayo Clinic was extensive rapidly accumulating one of the world鈥檚 largest experiences in aortic disease, where he led and build an advanced endovascular aortic program over the last two decades. He is one of ten surgeons in the United States, and the only surgeon in Houston to have physician-sponsored, Food Drug Administration (FDA) approved access to the entire pipeline of company-manufactured fenestrated and branched stent-grafts to treat aortic arch, thoracoabdominal and complex abdominal aortic aneurysms. Dr. Oderich has also a versatile open surgical and endovascular practice in other areas, including the management of carotid, supra-aortic trunk, renal, and mesenteric artery diseases. He is also involved in the multidisciplinary care of patients with connective tissue or heritable disorders including Marfan鈥檚, Loeys-Dietz Syndrome and Vascular Ehlers Danlos Syndrome. Dr. Oderich is also devoted to surgical education and the dissemination of these techniques, having mentored to over 100 residents, fellows and post-graduate students. He is considered one of the most influential aortic surgeons worldwide.
Videos
Projects
- Physician-modified endovascular grafts or PMEGs
- Because access to fenestrated and branched endograft is limited in the United States due to regulatory approval, most surgeons rely on creative modification of other devices to treat patients. These PMEG techniques have been largely pioneered and described by Dr. Oderich between 2007 and 2010. Limitations of PMEGs include no company quality control, limited versatily of stent design and lack long-term data. Dr. Oderich uses PMEGs in a minority patients who need urgent procedures or do not quality for currently approved or investigational devices
- Clinical Practice Guidelines for Management of Aortic Diseases
- As a leader in management of aortic disease, Dr. Oderich has contributed in the writing committee of the most important guidelines that define indications and methods of treatment of aortic aneurysms, including the latest guidelines from the American Heart Association, the Society for Vascular Surgery in the United States and the European Society for Vascular and Endovascular Surgery.
- Dr. Oderich鈥檚 Physician Sponsored, FDA-approved, Investigational Device Exemption Studies (G130030 and G130266)
- Dr. Oderich is one of a few surgeons in the United States that has access to a wide pipeline of stent-graft designs for the treatment of aortic arch and thoracoabdominal aortic aneurysms. This program started under his leadership at the Mayo Clinic Aortic Center and is now at Baylor. Dr. Oderich spearheaded and developed extensive clinical experience and innovations in aortic stent-graft design, novel techniques, imaging and clinical data that support indications for the use of minimally invasive endovascular approaches. One of the most impressive contributions by Dr. Oderich is the reporting of one of the largest single-surgeon experiences with the use of fenestrated-branched endovascular repair of aortic aneurysms and dissections using such devices, with significant reduction in mortality and morbidity and one of the lowest (if not the lowest) operative mortalities worldwide. As a comparison, Dr. Oderich mortality for endovascular repair of thoracoabdominal aortic aneurysms has been consistently in the range of 1 to 1.5%, which is remarkably lower than the expected 15% mortality for open surgical repair in national datasets or 7-15% in single center open surgical experiences.
Memberships
- American College of Surgeons
- American Medical Association
- American Surgical Association
- Associacao dos Medicos do Rio Grande do Sul
- American Venous Forum
- Association for Academic Surgery
- Association of Program Directors in Vascular Surgery
- International Society for Cardiovascular Surgery
- Midwestern Vascular Surgical Society
- Society for Vascular Surgery
- Texas Surgical Society
- Priestley Society
- International Society of Endovascular Specialists
- President-elect
- Peruvian Vascular Surgery Society
- Honorary Member
to edit your profile